Drug Company to Share Revenues With Indigenous People Who Donated Their Genes
Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes.
Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes.
This Viewpoint discusses significant revisions in the Declaration of Helsinki in response to changing ethical norms and technologies.
This cohort study examines uptake of maternal respiratory syncytial virus (RSV) vaccination and infant receipt of nirsevimab during the early period of availability for these…
Family physicians saw improvements in workplace culture but questioned the effectiveness of RVU metrics to measure productivity.
Another great-looking small computer.
Investors are optimistic about the potential for mergers, acquisitions and initial public offerings in 2025.
Nvidia’s Cosmos platform lets researchers simulate multiple different realities and simulate real-world physics to generate footage that can train future robots.
This Viewpoint discusses the 2024 revisions made to the Declaration of Helsinki as it continues to work toward ensuring research is subject to ethical standards…
This systematic review examines academic detailing programs targeted at improving prescribing behavior and describes program aspects associated with positive outcomes.
Scribe Therapeutics, co-founded by Jennifer Doudna, is reducing staff, the latest layoffs among companies focused on CRISPR therapies.
This Viewpoint examines the disaster response and climate health concepts following the 2023 Lāhainā wildfires in Maui through the perspective of Native Hawaiian leaders and…